Agios Pharmaceuticals(AGIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AGIO Agios Pharmaceuticals

Trading 10-29 11:46:13 EDT

37.66

-0.46

-1.22%

High38.49	Low37.55	Vol155.64K
Open38.23	D1 Closing38.12	Amplitude2.47%
Mkt Cap2.24B	Tradable Cap1.89B	Total Shares59.47M
T/O5.92M	T/O Rate0.31%	Tradable Shares50.09M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AGIO","market":"US","secType":"STK","nameCN":"Agios Pharmaceuticals","latestPrice":37.655,"timestamp":1793288760185,"preClose":38.12,"halted":0,"volume":155636,"delay":0,"changeRate":-0.012198321091290565,"floatShares":50088500,"shares":59471609,"eps":-7.007511,"marketStatus":"Trading","change":-0.465,"latestTime":"10-29 11:46:13 EDT","open":38.23,"high":38.49,"low":37.55,"amount":5919033.959539999,"amplitude":0.024659,"askPrice":37.69,"askSize":200,"bidPrice":37.61,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-7.007511,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793304000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1374638400000,"exchange":"NASDAQ","adjPreClose":38.12,"preHourTrading":{"tag":"盘前","latestPrice":38.04,"preClose":38.12,"latestTime":"09:25 EDT","volume":1208,"amount":46250.621104,"timestamp":1793280300072,"change":-0.08,"changeRate":-0.002099,"amplitude":0.101784},"postHourTrading":{"tag":"盘后","latestPrice":38.162647,"preClose":38.12,"latestTime":"19:30 EDT","volume":503284,"amount":19185247.869572,"timestamp":1793230202251,"change":0.042647,"changeRate":0.001119,"amplitude":0.001119},"volumeRatio":0.458662,"impliedVol":0.9038,"impliedVolPercentile":0.8566},"requestUrl":"/m/hq/s/AGIO","defaultTab":"news","newsList":[{"id":"1129379678","title":"Earning Preview: Agios Pharmaceuticals Q3 revenue is expected to increase by 416%, and institutional views are cautiously bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1129379678","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1129379678?lang=en_us&edition=fundamental","pubTime":"2026-10-29 22:32","pubTimestamp":1793284364,"startTime":"0","endTime":"0","summary":"Abstract Agios Pharmaceuticals will report its quarterly results on November 5, 2026 Pre-MKt; this preview highlights expected revenue growth, margin trajectory, and adjusted EPS outlook grounded in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Agios Pharmaceuticals Q3 revenue is expected to increase by 416%, and institutional views are cautiously bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679288070","title":"Agios Pharmaceuticals Coverage Assumed by HC Wainwright & Co. at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2679288070","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679288070?lang=en_us&edition=fundamental","pubTime":"2026-10-29 21:26","pubTimestamp":1793280360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AGIO/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679416505","title":"Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens Reports Sale of $296,469.54 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2679416505","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679416505?lang=en_us&edition=fundamental","pubTime":"2026-10-29 04:03","pubTimestamp":1793217825,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens Reports Sale of $296,469.54 in Common SharesAgios Pharmaceuticals Chief Medical Officer Sarah Gheuens sold 7,866 common shares Oct. 26, 2026, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nNDL6b32Ft:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens Reports Sale of $296,469.54 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678469538","title":"Citi Keeps Their Buy Rating on Agios Pharma (AGIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2678469538","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678469538?lang=en_us&edition=fundamental","pubTime":"2026-10-28 18:56","pubTimestamp":1793185012,"startTime":"0","endTime":"0","summary":"In a report released today, Samantha Semenkow from Citi maintained a Buy rating on Agios Pharma, with a price target of $52.00. According to TipRan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-keeps-their-buy-rating-on-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-keeps-their-buy-rating-on-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677729959","title":"Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens Reports Sale of $74,642.17 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2677729959","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677729959?lang=en_us&edition=fundamental","pubTime":"2026-10-24 04:07","pubTimestamp":1792786049,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens Reports Sale of $74,642.17 in Common SharesAgios Pharmaceuticals Chief Medical Officer Sarah Gheuens sold 1,489 common shares at $37.53 on Oct","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nNDL6ngRMx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens Reports Sale of $74,642.17 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677952742","title":"Agios Pharmaceuticals, Inc. : Leerink Partners Cuts Target Price to $72 from $73","url":"https://stock-news.laohu8.com/highlight/detail?id=2677952742","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677952742?lang=en_us&edition=fundamental","pubTime":"2026-10-22 19:12","pubTimestamp":1792667559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nFWN4681Z3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675561958","title":"How Investors May Respond To Agios Pharmaceuticals (AGIO) Sickle Cell FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2675561958","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675561958?lang=en_us&edition=fundamental","pubTime":"2026-10-16 14:33","pubTimestamp":1792132400,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals recently received an FDA priority review for its oral pyruvate kinase activator mitapivat in sickle cell disease, with a regulatory decision expected by November 1 and potential to extend use beyond its current indications.\nThe review highlights how Agios is trying to widen its rare disease footprint by reusing an existing medicine in a new, genetically defined patient group. This could reshape the mix of revenue sources if the therapy reaches this broader...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agio/agios-pharmaceuticals/news/how-investors-may-respond-to-agios-pharmaceuticals-agio-sick","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agio/agios-pharmaceuticals/news/how-investors-may-respond-to-agios-pharmaceuticals-agio-sick","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ISBC","AGIO","LABU","BK4211","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674888234","title":"Agios Pharma (AGIO) Gets a Hold from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2674888234","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674888234?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:47","pubTimestamp":1791510452,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Luca Issi maintained a Hold rating on Agios Pharma yesterday and set a price target of $32.00. According to TipRanks, Issi is a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/agios-pharma-agio-gets-a-hold-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/agios-pharma-agio-gets-a-hold-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSIB","LU0708994859.HKD","BK4139","LU0310800379.SGD","LU1267930573.SGD","AGIO","LU0128525929.USD","LU0029864427.USD","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673019974","title":"Agios Pharmaceuticals Price Target Cut to $37.00/Share from $39.00 by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2673019974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673019974?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:14","pubTimestamp":1791386040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AGIO/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673013709","title":"Agios Pharmaceuticals price target lowered to $37 from $39 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2673013709","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673013709?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:07","pubTimestamp":1791378451,"startTime":"0","endTime":"0","summary":"Truist lowered the firm’s price target on Agios Pharmaceuticals (AGIO) to $37 from $39 and keeps a Buy rating on the shares as part of a broader re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-lowered-to-37-from-39-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-lowered-to-37-from-39-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669632901","title":"BofA Securities Adjusts Agios Pharmaceuticals Price Target to $50 From $46, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2669632901","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669632901?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:19","pubTimestamp":1789993149,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals (AGIO) has an average rating of overweight and mean price target of $42.62, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669509461","title":"Agios Pharmaceuticals price target raised to $50 from $46 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2669509461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669509461?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:40","pubTimestamp":1789987225,"startTime":"0","endTime":"0","summary":"BofA raised the firm’s price target on Agios Pharmaceuticals (AGIO) to $50 from $46 and keeps a Buy rating on the shares. Despite falling off all-t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-raised-to-50-from-46-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-raised-to-50-from-46-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660587452","title":"Agios Pharmaceuticals (AGIO) Could Be 24% Undervalued On PYRUKYND Growth Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2660587452","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660587452?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:22","pubTimestamp":1787030537,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals (AGIO) has drawn investor focus after recent trading left the stock at a last close of $33.63. With mixed return figures across different periods, the company’s rare disease portfolio is gaining fresh attention.\nSee our latest analysis for Agios Pharmaceuticals.\nOver the past year, Agios Pharmaceuticals has combined a 23.73% year to date share price return with a 21.28% 90 day share price gain, yet the 1 year total shareholder return declined 10.20%. This suggests that...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agio/agios-pharmaceuticals/news/agios-pharmaceuticals-agio-could-be-24-undervalued-on-pyruky","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agio/agios-pharmaceuticals/news/agios-pharmaceuticals-agio-could-be-24-undervalued-on-pyruky","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658913504","title":"Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658913504","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658913504?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:00","pubTimestamp":1786453226,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","IE0002270589.USD","BK4588","LU0320765992.SGD","LU1261432733.SGD","LU0157215616.USD","BK4139","XAR","LU2089984988.USD","MISL","UXI","LU0353189680.USD","LU0058720904.USD","LU2756315318.SGD","IBBQ","GEHC","LU1559883803.SGD","VERX","LU0820561909.HKD","LU1084165304.USD","SG9999001176.SGD","VRTX","LU0757428866.USD","BIB","GE","LU1093756325.SGD","PPA","GNMX","TBXU","IE00B19Z9P08.USD","LU0267386448.USD","LU0417517546.SGD","XBI","TRUI","LU2756315664.SGD","EXI","DFEN","NATO","IE0009355771.USD","ITA","LU2417539215.USD","PBE","METV","XLV","LABU","BK4532","AGIO","LGHT","BBH","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658675029","title":"Agios Pharmaceuticals (AGIO) In Focus On Earnings As Undervalued Narrative Holds","url":"https://stock-news.laohu8.com/highlight/detail?id=2658675029","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658675029?lang=en_us&edition=fundamental","pubTime":"2026-08-09 04:19","pubTimestamp":1786220398,"startTime":"0","endTime":"0","summary":"Earnings event puts Agios Pharmaceuticals stock in focus\nAgios Pharmaceuticals (AGIO) reported second quarter 2026 results on July 30, with revenue of US$44.75 million and a net loss of US$100.7 million. Revenue and loss figures also shifted for the first half.\nSee our latest analysis for Agios Pharmaceuticals.\nThe earnings release appears to have sharpened investor attention on Agios Pharmaceuticals, with a 7.5% 7 day share price return and a 16.1% 90 day share price return standing against...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agio/agios-pharmaceuticals/news/agios-pharmaceuticals-agio-in-focus-on-earnings-as-undervalu","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agio/agios-pharmaceuticals/news/agios-pharmaceuticals-agio-in-focus-on-earnings-as-undervalu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656587661","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656587661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656587661?lang=en_us&edition=fundamental","pubTime":"2026-08-04 13:30","pubTimestamp":1785821407,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-agios-pharma-agio-novavax-nvax-and-keros-therapeutics-kros-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-agios-pharma-agio-novavax-nvax-and-keros-therapeutics-kros-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LABU","LU0029874061.USD","AGIO","HCSG","LU0128526141.USD","BK4581","BK4588","NVAX","BK4568","XLV","BK4139","BK4585","XBI","BK4547","KROS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656299423","title":"U.S. Research Roundup-Abbvie, Amazon, Illumina","url":"https://stock-news.laohu8.com/highlight/detail?id=2656299423","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656299423?lang=en_us&edition=fundamental","pubTime":"2026-08-03 15:46","pubTimestamp":1785743176,"startTime":"0","endTime":"0","summary":"CORRECTED-U.S. RESEARCH ROUNDUP-Abbvie, Amazon, IlluminaAug 3 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbvie, Amaz","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4N4400J3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLG","CHD","AGM","AMH","AMTB","GLPI","CVX","ERX","BRO","AZYY","BBT","GTES","BEPC","CL","ARES","AGIO","BKU","CBNK","ONLN","IR","WANT","CBU","BOH","EGP","AMZN","FULT","CBNA","CTSH","IYE","CNO","FHN","CRCL","FTAI","IXJ","FMC","GDDY","HUN","JDOC","IYH","BOKF","CATY","CFR","XOM","VDE","FBIZ","GPC","TBBK","ABBV","FTXO","BLCK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656734085","title":"Agios Pharmaceuticals Inc : Leerink Partners Raises Target Price to $73 from $62","url":"https://stock-news.laohu8.com/highlight/detail?id=2656734085","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656734085?lang=en_us&edition=fundamental","pubTime":"2026-08-03 12:36","pubTimestamp":1785731803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN43Y0CW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655047369","title":"Agios Pharmaceuticals is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2655047369","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655047369?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:05","pubTimestamp":1785503100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AGIO/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655687703","title":"Agios Pharmaceuticals Inc : Truist Securities Cuts Target Price to $39 from $41","url":"https://stock-news.laohu8.com/highlight/detail?id=2655687703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655687703?lang=en_us&edition=fundamental","pubTime":"2026-07-31 19:12","pubTimestamp":1785496329,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X24J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agios.com","stockEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":0.1406},{"period":"3month","weight":0.164},{"period":"6month","weight":0.3537},{"period":"1year","weight":-0.1223},{"period":"ytd","weight":0.4004}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.1241},{"period":"ytd","weight":0.1326}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.846154,"avgChangeRate":0.040392},{"month":2,"riseRate":0.692308,"avgChangeRate":0.060535},{"month":3,"riseRate":0.538462,"avgChangeRate":-0.001595},{"month":4,"riseRate":0.538462,"avgChangeRate":-0.007034},{"month":5,"riseRate":0.615385,"avgChangeRate":0.052079},{"month":6,"riseRate":0.692308,"avgChangeRate":0.062482},{"month":7,"riseRate":0.384615,"avgChangeRate":-0.026027},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.029781},{"month":9,"riseRate":0.5,"avgChangeRate":0.038951},{"month":10,"riseRate":0.428571,"avgChangeRate":0.003893},{"month":11,"riseRate":0.615385,"avgChangeRate":0.033339},{"month":12,"riseRate":0.384615,"avgChangeRate":-0.051358}],"exchange":"NASDAQ","name":"Agios Pharmaceuticals","nameEN":"Agios Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agios Pharmaceuticals(AGIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Agios Pharmaceuticals(AGIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Agios Pharmaceuticals,AGIO,Agios Pharmaceuticals股票,Agios Pharmaceuticals股票老虎,Agios Pharmaceuticals股票老虎国际,Agios Pharmaceuticals行情,Agios Pharmaceuticals股票行情,Agios Pharmaceuticals股价,Agios Pharmaceuticals股市,Agios Pharmaceuticals股票价格,Agios Pharmaceuticals股票交易,Agios Pharmaceuticals股票购买,Agios Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agios Pharmaceuticals(AGIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Agios Pharmaceuticals(AGIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction